A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis

被引:0
作者
Misaki Hirose
Tomoya Nishino
Tadashi Uramatsu
Yoko Obata
Mineaki Kitamura
Tayo Kawazu
Masanobu Miyazaki
Takashi Taguchi
Shigeru Kohno
机构
[1] Nagasaki University School of Medicine,Second Department of Internal Medicine
[2] Nagasaki University Hospital,Division of Blood Purification
[3] Nagasaki University Hospital,Medical Education Development Center
[4] Miyazaki Clinic,Department of Pathology
[5] Nagasaki University Graduate School of Biomedical Sciences,undefined
来源
Clinical and Experimental Nephrology | 2012年 / 16卷
关键词
IgA nephropathy; Minimal change nephrotic syndrome; Mesangial IgA deposition; Focal segmental glomerulosclerosis; Nephrotic syndrome; Influenza virus vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
A 50-year-old woman with a 1-month history of lower extremity edema and a 5 kg weight increase was admitted to our hospital with suspected nephrotic syndrome in October 1999. Urine protein level was 3.5 g per day, 10−15 erythrocytes in urine per high-power field, and serum albumin level 2.5 g/dl. Furthermore, an accumulation of pleural effusion was confirmed by chest X-ray. The results of a renal biopsy indicated slight mesangial proliferation in the glomeruli by light microscopy, and an immunofluorescence study confirmed the deposition of immunoglobulin (Ig) A and C3 in the mesangial area. Diffuse attenuation of foot processes and dense deposits in the mesangial area were observed by electron microscopy. Treatment with 40 mg/day of prednisolone was effective, and proteinuria was negative 1 month later. Because of this course, we diagnosed minimal change nephrotic syndrome complicated by mild-proliferative IgA nephropathy. In November 2000, there was a relapse of nephrotic syndrome, which was believed to be induced by an influenza vaccination, but response to increased steroid treatment was favorable, and proteinuria disappeared on day 13 of steroid increase. A second relapse in May 2001, showed steroid resistance with renal insufficiency, and an increase in the selectivity index to 0.195. Light microscopy revealed focal sclerotic lesions of the glomeruli, and an immunofluorescence study revealed attenuation of mesangial IgA and C3 deposition. These findings led to the diagnosis that minimal change nephrotic syndrome had transitioned to focal segmental glomerulosclerosis, whereby mesangial IgA deposition was reduced by immunosuppressive treatment. Subsequently, her renal function gradually worsened to the point of end-stage renal failure by 27 months after the second relapse of nephrotic syndrome.
引用
收藏
页码:473 / 479
页数:6
相关论文
共 50 条
  • [31] Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
    Fernandez-Juarez, Gema
    Villacorta, Javier
    Ruiz-Roso, Gloria
    Panizo, Nayara
    Martinez-Marin, Isabel
    Marco, Helena
    Arrizabalaga, Pilar
    Diaz, Montserrat
    Perez-Gomez, Vanessa
    Vaca, Marco
    Rodriguez, Eva
    Cobelo, Carmen
    Fernandez, Loreto
    Avila, Ana
    Praga, Manuel
    Quereda, Carlos
    Ortiz, Alberto
    CLINICAL KIDNEY JOURNAL, 2016, 9 (03): : 381 - 386
  • [32] Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
    Hulkko, Jenny
    Patrakka, Jaakko
    Lal, Mark
    Tryggvason, Karl
    Hultenby, Kjell
    Wernerson, Annika
    NEPHRON EXTRA, 2014, 4 (03): : 146 - 154
  • [33] Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis
    Bu, Lihong
    Mirocha, James
    Haas, Mark
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1016 - 1022
  • [34] Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis
    Jian Liu
    Weiming Wang
    Frontiers of Medicine, 2017, 11 : 333 - 339
  • [35] Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: Clinicopathological correlations
    Greenberg, A
    Bastacky, SI
    Iqbal, A
    Borochovitz, D
    Johnson, JP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (03) : 334 - 344
  • [36] Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis
    Liu, Jian
    Wang, Weiming
    FRONTIERS OF MEDICINE, 2017, 11 (03) : 333 - 339
  • [37] Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study
    Paul, E. Nithin
    Satish, Suchitha
    Kelur, Kiran Krishnamurthy
    Shetty, Manjunath Sanjeev
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (03) : 526 - 532
  • [38] Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis
    Sharif, Bedra
    Barua, Moumita
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (03) : 194 - 200
  • [39] Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome
    Shi-jun Li
    Yuan-Mao Tu
    Chang-sheng Zhou
    Li-Hua Zhang
    Zhi-hong Liu
    Clinical and Experimental Nephrology, 2016, 20 : 212 - 217
  • [40] Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome
    Li, Shi-jun
    Tu, Yuan-Mao
    Zhou, Chang-sheng
    Zhang, Li-Hua
    Liu, Zhi-hong
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (02) : 212 - 217